New drug ARC101 enters first human tests for Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase study tests a new drug called ARC101 in 70 people with advanced solid tumors that have a specific marker (Claudin 6). The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. Participants must have ovarian, testicular, or ot…
Phase: PHASE1 • Sponsor: Third Arc Bio • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC